Clinical Trial Update: Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing photodynamic therapy plus ranibizumab versus ranibizumab alone in persistent polypoidal choroidal vasculopathy associate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Age-related Macular Degeneration | Phase 4 | Status: UNKNOWN